Author:
Blum Kristie A.,Advani Anjani,Fernandez Louis,Van Der Jagt Richard,Brandwein Joseph,Kambhampati Suman,Kassis Jeannine,Davis Melanie,Bonfils Claire,Dubay Marja,Dumouchel Julie,Drouin Michel,Lucas David M.,Martell Robert E.,Byrd John C.
Reference29 articles.
1. Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein;Aron;Blood,2003
2. Phase I trial of suberoylanilide hydroxamic acid (SAHA) + bortezomib (Bort) in relapsed multiple myeloma (MM) patients (pts);Badros;Blood (American Society of Hematology Annual Meeting Abstracts),2007
3. Frequent methylation silencing of p15/INK4b (MTS2)and p16/INK4a (MTS1) in B-cell and T-cell lymphomas;Baur;Blood,1999
4. A phase I evaluation of low dose decitabine targeting DNA hypermethylation in patients with chronic lymphocytic leukemia (CLL) and Non-Hodgkin’s Lymphoma (NHL): dose-limiting myelosuppression without evidence of hypomethylation;Blum;Blood (American Society of Hematology Annual Meeting Abstracts),2008
5. Isotype-selective histone deacetylase inhibitor MGCD0103 demonstrates clinical activity and safety in patients with relapsed/refractory classical Hodgkin lymphoma (HL);Bociek;Journal of Clinical Oncology (Proceedings of the American Society of Clinical Oncology),2008
Cited by
104 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献